Gene · 537
Papers1,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antiangiogenics in Malignant Granular Cell Tumors: Review of the Literature. | Cancers (Basel) | 2023 | 37958362 | PubTator, text mining | PubMed |
| Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivatives. | Sci Rep | 2023 | 37949940 | PubTator, text mining | PubMed |
| Potential Toxic elements in shellfish from three rivers in Niger Delta, Nigeria: bioaccumulation, dietary intake, and human health risk assessment. | Environ Anal Health Toxicol | 2023 | 37933105 | PubTator, text mining | PubMed |
| Metabolism of pancreatic neuroendocrine tumors: what can omics tell us? | Front Endocrinol (Lausanne) | 2023 | 37908747 | PubTator, text mining | PubMed |
| Easy Access to Sauropunols A-D: Synthesis and Spectroscopy Correlation of Their Natural Methyl and Ethyl Glycosides. | ACS Omega | 2023 | 37901566 | PubTator, text mining | PubMed |
| New insights into the pathogenesis of primary biliary cholangitis asymptomatic stage. | World J Gastroenterol | 2023 | 37899787 | PubTator, text mining | PubMed |
| Integrated Analysis of Transcriptome and Proteome of the Human Cornea and Aqueous Humor Reveal Novel Biomarkers for Corneal Endothelial Cell Dysfunction. | Int J Mol Sci | 2023 | 37895034 | PubTator, text mining | PubMed |
| Uncovering per- and polyfluoroalkyl substances (PFAS) with nontargeted ion mobility spectrometry-mass spectrometry analyses. | Sci Adv | 2023 | 37878714 | PubTator, text mining | PubMed |
| 2023 APHL/ISNS Newborn Screening Symposium. | Int J Neonatal Screen | 2023 | 37873845 | PubTator, text mining | PubMed |
| Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention. | Front Immunol | 2023 | 37868953 | PubTator, text mining | PubMed |
| Congenital disorders of glycosylation (CDG): state of the art in 2022. | Orphanet J Rare Dis | 2023 | 37858231 | PubTator, text mining | PubMed |
| Biosynthesis and engineering of the nonribosomal peptides with a C-terminal putrescine. | Nat Commun | 2023 | 37857663 | PubTator, text mining | PubMed |
| Case report: Giant atypical granular cell tumor of the median nerve. | Front Neurol | 2023 | 37840916 | PubTator, text mining | PubMed |
| Epigenetic mechanism of Gtl2-miRNAs causes the primitive sheep characteristics found in purebred Merino sheep. | Cell Biosci | 2023 | 37828606 | PubTator, text mining | PubMed |
| What do we know about the function of SARS-CoV-2 proteins? | Front Immunol | 2023 | 37790934 | PubTator, text mining | PubMed |
| Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation. | Ther Adv Endocrinol Metab | 2023 | 37780174 | PubTator, text mining | PubMed |
| Ligustrazine-Derived Chalcones-Modified Platinum(IV) Complexes Intervene in Cisplatin Resistance in Pancreatic Cancer through Ferroptosis and Apoptosis. | J Med Chem | 2023 | 37766483 | PubTator, text mining | PubMed |
| Identification of a muscle-specific isoform of VMA21 as a potent actor in X-linked myopathy with excessive autophagy pathogenesis. | Hum Mol Genet | 2023 | 37756622 | PubTator, text mining | PubMed |
| Dose-Response Activity-Based DNA-Encoded Library Screening. | ACS Med Chem Lett | 2023 | 37736190 | PubTator, text mining | PubMed |
| The role of cell death in SARS-CoV-2 infection. | Signal Transduct Target Ther | 2023 | 37726282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/537/papers?page=6